releases

Consensus Guidelines for the Use of Peripheral Nerve Stimulation in the Treatment of Chronic Pain and Neurological Diseases: A Neuron Project from the American Society of Pain and Neuroscience

Peripheral nerve stimulation (PNS) has evolved substantially over recent...

releases

Boston Scientific Announces Agreement to Acquire Nalu Medical, Inc.

Link to Boston Scientific Press Release Boston Scientific Corporation (NYSE: BSX)...

releases

Nalu Advances Wearable Neurostimulation with New, 39% Smaller Therapy Disc

CARLSBAD, Calif. (BUSINESS WIRE) August 21, 2025 — Nalu Medical Inc.,...

releases

CareFirst BCBS Recognizes Nalu Neurostimulation System as Medically Necessary for Chronic Peripheral Pain, Expanding Access to 3.5 Million Covered Lives

CARLSBAD, Calif. (BUSINESS WIRE) August 6, 2025 — Nalu Medical, Inc., a...

releases

Nalu Announces Publication of Results from COMFORT 2 Randomized Control Trial (RCT) Making Nalu the First Permanent PNS Device to Demonstrate Level-1 Clinical Evidence

CARLSBAD, Calif. (BUSINESS WIRE) Aug 5, 2025 –– The results of...

releases

Nalu Medical Achieves National Payer Milestone with Aetna Coverage for PNS Therapy

Nalu Medical Achieves National Payer Milestone with Aetna Coverage for PNS...

releases

Nalu Announces Publication of the Largest Long-Term Report of Real-World Data (RWD) on a Permanent PNS Device

CARLSBAD, Calif. (BUSINESS WIRE) May 8, 2025 — Publication of the Nalu...

releases

Nalu Medical Appoints Veteran Medtech Executive Raymond W. Cohen Chairman of its Board of Directors

CARLSBAD, Calif. (BUSINESS WIRE) Apr 3, 2025 — Nalu Medical, Inc. (“Nalu”)...

releases

Nalu Expands MRI-Conditional Labeling for Peripheral Nerve Stimulation with FDA Clearance for Whole-Body MRI

CARLSBAD, Calif. (BUSINESS WIRE) Jan 21, 2025 — Nalu Medical announces the...

releases

Nalu PNS System Significantly Reduces Healthcare-Related Costs in Chronic Pain Patients

CARLSBAD, Calif. (BUSINESS WIRE) Jan 8, 2025 — Nalu Medical, Inc. (“Nalu”),...

releases

Nalu 1-Year PNS Data Show Durable Pain Relief and Significant Functional Improvement

CARLSBAD, Calif. (BUSINESS WIRE) Dec 3, 2024 — One-year data from the Nalu...

releases

Nalu PNS System achieves significant and durable pain reduction, meeting the primary endpoint of the COMFORT RCT study

CARLSBAD, Calif. (BUSINESS WIRE) June 4, 2024 Nalu Medical Inc. (“Nalu”) revealed...

Events

NY & NJ Pain Medicine Congress

North American Neurological Society (NANS)

News

Consensus Guidelines for the Use of Peripheral Nerve Stimulation in the Treatment of Chronic Pain and Neurological Diseases: A Neuron Project from the American Society of Pain and Neuroscience

Boston Scientific Announces Agreement to Acquire Nalu Medical, Inc.

Nalu Advances Wearable Neurostimulation with New, 39% Smaller Therapy Disc

CareFirst BCBS Recognizes Nalu Neurostimulation System as Medically Necessary for Chronic Peripheral Pain, Expanding Access to 3.5 Million Covered Lives

Nalu Announces Publication of Results from COMFORT 2 Randomized Control Trial (RCT) Making Nalu the First Permanent PNS Device to Demonstrate Level-1 Clinical Evidence

Nalu Medical Achieves National Payer Milestone with Aetna Coverage for PNS Therapy

Nalu Announces Publication of the Largest Long-Term Report of Real-World Data (RWD) on a Permanent PNS Device

Nalu Medical Appoints Veteran Medtech Executive Raymond W. Cohen Chairman of its Board of Directors

Nalu Expands MRI-Conditional Labeling for Peripheral Nerve Stimulation with FDA Clearance for Whole-Body MRI

Nalu PNS System Significantly Reduces Healthcare-Related Costs in Chronic Pain Patients

Nalu 1-Year PNS Data Show Durable Pain Relief and Significant Functional Improvement

Nalu PNS System achieves significant and durable pain reduction, meeting the primary endpoint of the COMFORT RCT study

Nalu Medical